Vaxxas
3 known investors
Biotechnology company enhancing vaccine performance with its HD-MAP high-density microarray skin-delivery platform, targeting infectious disease and oncology.
Investors · 3
Competitors · 7
by search overlap
Vaccinex25 shared keywordsVaccinex is a clinical-stage biotechnology company developing pepinemab (VX15/2503), a humanized monoclonal antibody that blocks SEMA4D signaling, in trials for neurological disorders such as Huntington's and Alzheimer's disease and for solid tumors including breast cancer, melanoma, non-small cell lung cancer and head and neck cancer. It also offers a fusion protein and ActivMab antibody discovery technology for incorporating membrane proteins such as GPCRs and ion channels into poxviruses for antibody selection.
Dynavax NASDAQ: DVAX www.dynavax.com23 shared keywordsDynavax is a commercial-stage biopharmaceutical company that develops and commercializes vaccines against infectious diseases using its adjuvant technology. Its products target immunization and infectious disease prevention.
Vaxcyte17 shared keywordsVaxcyte develops broad-spectrum vaccines to prevent bacterial infections, using a cell-free protein synthesis platform and synthetic chemistry techniques. Its pipeline includes pneumococcal conjugate vaccines (VAX-31 and VAX-24) and early-stage candidates targeting Group A Strep and Shigella.
Abivax15 shared keywordsAbivax develops obefazimod, an orally administered small molecule drug candidate with a novel mechanism of action targeting microRNA biology to treat chronic inflammatory diseases including ulcerative colitis and Crohn's disease.
VaxCare13 shared keywordsVaxCare operates a platform that automates procurement, inventory management, patient eligibility, charting, and billing for vaccines and contraceptives at medical practices. It serves health systems, pediatric, family medicine, OB-GYN, and internal medicine practices, connecting suppliers, EHRs, and payers to keep practices stocked with ACIP-recommended vaccines and contraceptives.
Centivax13 shared keywordsCentivax is a biotechnology company developing broad-spectrum vaccines, including a universal influenza vaccine.
Imvax12 shared keywordsImvax is a clinical-stage biopharmaceutical company developing personalized immunotherapies aimed at treating solid tumors, including glioblastoma. Its platform draws on autologous, cell-based approaches to target cancer.
Companies competing with Vaxxas for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Vaxxas do?
- Biotechnology company enhancing vaccine performance with its HD-MAP high-density microarray skin-delivery platform, targeting infectious disease and oncology.
- Who are Vaxxas's investors?
- Vaxxas's investors include R&D Tax Incentive, Torrey Pines Investment, OneVentures.